Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2016 - 2021)

Historic Change in Acquisitions & Divestments for Akebia Therapeutics (AKBA) over the last 6 years, with Q2 2021 value amounting to $20.0 million.

  • Akebia Therapeutics' Change in Acquisitions & Divestments changed N/A to $20.0 million in Q2 2021 from the same period last year, while for Mar 2022 it was $20.0 million, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $40.0 million for FY2021, which is 3360.44% down from last year.
  • Per Akebia Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $20.0 million for Q2 2021.
  • In the past 5 years, Akebia Therapeutics' Change in Acquisitions & Divestments ranged from a high of $78.7 million in Q1 2019 and a low of $245000.0 during Q1 2020
  • Over the past 5 years, Akebia Therapeutics' median Change in Acquisitions & Divestments value was $36.7 million (recorded in 2017), while the average stood at $40.4 million.
  • As far as peak fluctuations go, Akebia Therapeutics' Change in Acquisitions & Divestments tumbled by 9968.87% in 2020, and later surged by 806326.53% in 2021.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Change in Acquisitions & Divestments stood at $52.1 million in 2017, then rose by 21.19% to $63.2 million in 2018, then tumbled by 64.39% to $22.5 million in 2019, then skyrocketed by 166.67% to $60.0 million in 2020, then plummeted by 66.67% to $20.0 million in 2021.
  • Its Change in Acquisitions & Divestments was $20.0 million in Q2 2021, compared to $20.0 million in Q1 2021 and $60.0 million in Q4 2020.